Register | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

eisei's library [631 articles]

Recent papers added to eisei's library.
  • An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Journal of immunological methods, Vol. 321, No. 1-2. (10 April 2007), pp. 94-106.
    by F Milano, JW van Baal, AM Rygiel, JJ Bergman, SJ Van Deventer, ML Kapsenberg, MP Peppelenbosch, KK Krishnadath
    posted to rna mrna by eisei on 2008-07-24 13:39:38 as **
  • Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
    Journal of immunotherapy (Hagerstown, Md. : 1997), Vol. 30, No. 6. (September 2007), pp. 663-674.
    by M Erdmann, J Dörrie, N Schaft, E Strasser, M Hendelmeier, E Kämpgen, G Schuler, B Schuler-Thurner
    posted to transfection mrna by eisei on 2008-07-24 12:01:10 as **
  • Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.
    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 13. (1 July 2008), pp. 4306-4315.
    by Y Sun, M Song, E Jäger, C Schwer, S Stevanovic, S Flindt, J Karbach, XD Nguyen, D Schadendorf, K Cichutek
    posted to no-tag by eisei on 2008-07-18 18:43:50 as **
  • TCR avidity: it's not how strong you make it, it's how you make it strong
    Nat Immunol, Vol. 2, No. 8. (2001), pp. 669-670.
    by David H Margulies
    posted to avidity by eisei on 2008-07-16 14:48:04 as **
  • Ex vivo identification, isolation and analysis of tumor-cytolytic T cells
    Nat Med, Vol. 9, No. 11. (November 2003), pp. 1377-1382.
    by Valerie Rubio, Tor B Stuge, Naileshni Singh, Michael R Betts, Jeffrey S Weber, Mario Roederer, Peter P Lee
    posted to cd107 by eisei on 2008-07-16 14:45:23 as **
  • Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels.
    The Journal of experimental medicine, Vol. 202, No. 1. (4 July 2005), pp. 33-45.
    by J Derbinski, J Gäbler, B Brors, S Tierling, S Jonnakuty, M Hergenhahn, L Peltonen, J Walter, B Kyewski
    posted to mtec aire by eisei on 2008-07-16 12:09:48 as **
  • Aire-ing self antigen variability and tolerance.
    European journal of immunology, Vol. 37, No. 3. (March 2007), pp. 598-601.
    by R Holmdahl
    posted to mtec aire by eisei on 2008-07-16 12:06:57 as **
  • Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.
    Oncogene, Vol. 23, No. 30. (1 July 2004), pp. 5252-5256.
    by AE Al Moustafa, WD Foulkes, A Wong, H Jallal, G Batist, Q Yu, M Herlyn, P Sicinski, MA Alaoui-Jamali
    posted to cyclin-d1 by eisei on 2008-07-15 16:51:37 as **
  • Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.
    Nature, Vol. 384, No. 6608. (5 December 1996), pp. 470-474.
    by P Sicinski, JL Donaher, Y Geng, SB Parker, H Gardner, MY Park, RL Robker, JS Richards, LK McGinnis, JD Biggers, JJ Eppig, RT Bronson, SJ Elledge, RA Weinberg
    posted to cyclins cyclin-d1 by eisei on 2008-07-15 16:48:56 as **
  • Identification of T-cell epitopes for cancer immunotherapy
    Leukemia, Vol. aop, No. current.
    by JH Kessler, CJM Melief
    posted to review prediction algorithm by eisei on 2008-07-15 16:25:18 as ** along with 1 person niallhaslam
  • Avidity maturation of memory CD8 T cells is limited by self-antigen expression
    J. Exp. Med. (14 July 2008), jem.20072390.
    by Michael J Turner, Evan R Jellison, Elizabeth G Lingenheld, Lynn Puddington, Leo Lefrancois
    posted to ova avidity by eisei on 2008-07-14 21:28:18 as **
  • Recognition of carcinoembryonic antigen peptide and heteroclitic peptide by peripheral blood T lymphocytes.
    Journal of immunotherapy (Hagerstown, Md. : 1997), Vol. 30, No. 3. (April 2007), pp. 350-358.
    by ME Brown, H Miao, MD McKee
    posted to cea cap1-6d cap1 avidity by eisei on 2008-07-14 09:42:40 as **
  • Lack of prognostic factors in follicular lymphoma.
    Leukemia & lymphoma, Vol. 44, No. 1. (January 2003), pp. 143-147.
    by A Avilés, N Neri, I Cuadra, I Alvarado, R Fernández, A Calva, J Huerta-Guzmán
    posted to follicular by eisei on 2008-07-11 09:10:49 as **
  • Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab.
    Leukemia & lymphoma, Vol. 47, No. 9. (September 2006), pp. 1830-1840.
    by MS Czuczman, AJ Grillo-López, B Alkuzweny, R Weaver, A Larocca, P McLaughlin
    posted to follicular by eisei on 2008-07-11 09:10:33 as **
  • Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
    Cancer, Vol. 110, No. 8. (15 October 2007), pp. 1803-1814.
    by IS Haldorsen, BK Krossnes, JH Aarseth, D Scheie, TB Johannesen, O Mella, A Espeland
    posted to pcnsl by eisei on 2008-07-11 08:58:48 as **
  • Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
    Acta oncologica (Stockholm, Sweden), Vol. 43, No. 6. (2004), pp. 520-529.
    by I Salvesen Haldorsen, JH Aarseth, A Hollender, JL Larsen, A Espeland, O Mella
    posted to pcnsl by eisei on 2008-07-11 08:56:21 as **
  • De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.
    Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 11. (15 March 2005), pp. 4103-4108.
    by MR Walker, BD Carson, GT Nepom, SF Ziegler, JH Buckner
    posted to treg by eisei on 2008-07-08 09:41:53 as **
  • FOXP3 Induced by CD28/B7 Interaction Regulates CD25 and Anergic Phenotype in Human CD4+CD25- T Lymphocytes
    J Immunol, Vol. 181, No. 2. (15 July 2008), pp. 1025-1033.
    by Cristiano Scotta, Marzia Soligo, Cristina Camperio, Enza Piccolella
    posted to treg by eisei on 2008-07-08 09:36:58 as **
  • Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs
    Int. Immunol., Vol. 19, No. 12. (1 December 2007), pp. 1413-1420.
    by Igor M Belyakov, Steven Kozlowski, Michael Mage, Jeffrey D Ahlers, Lisa F Boyd, David H Margulies, Jay A Berzofsky
    posted to avidity by eisei on 2008-07-07 18:44:03 as **
  • Liposomal co-entrapment of CD40mAb induces enhanced IgG responses against bacterial polysaccharide and protein.
    PLoS ONE, Vol. 3, No. 6. (2008)
    by C Hatzifoti, A Bacon, H Marriott, P Laing, AW Heath
    posted to cd40 by eisei on 2008-07-04 11:57:14 as **
  • Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells.
    Journal of immunology (Baltimore, Md. : 1950), Vol. 180, No. 5. (1 March 2008), pp. 3585-3593.
    by J Carrasco, A Van Pel, B Neyns, B Lethé, F Brasseur, N Renkvist, P van der Bruggen, N van Baren, R Paulus, K Thielemans, T Boon, D Godelaine
    posted to mage ctl by eisei on 2008-07-04 11:14:43 as **
  • Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.
    Immunity, Vol. 28, No. 3. (March 2008), pp. 414-424.
    by N Demotte, V Stroobant, PJ Courtoy, P Van Der Smissen, D Colau, IF Luescher, C Hivroz, J Nicaise, JL Squifflet, M Mourad, D Godelaine, T Boon, P van der Bruggen
    posted to tumor-infiltrating ctl anaergy by eisei on 2008-07-04 11:14:06 as **
  • Posttransplant Administration of Cyclophosphamide and Donor Lymphocyte Infusion Induces Potent Antitumor Immunity to Solid Tumor
    Clin Cancer Res, Vol. 14, No. 9. (1 May 2008), pp. 2833-2840.
    by Masatoshi Eto, Yoriyuki Kamiryo, Ario Takeuchi, Masahiko Harano, Katsunori Tatsugami, Mamoru Harada, Keijiro Kiyoshima, Masumitsu Hamaguchi, Takanori Teshima, Masazumi Tsuneyoshi, Yasunobu Yoshikai, Seiji Naito
    posted to post-transplantation-cyclophosphamide by eisei on 2008-07-01 10:23:22 as **
  • Multiple Costimulatory Modalities Enhance CTL Avidity
    J Immunol, Vol. 174, No. 10. (15 May 2005), pp. 5994-6004.
    by James W Hodge, Mala Chakraborty, Chie Kudo-Saito, Charlie T Garnett, Jeffrey Schlom
    posted to avidity by eisei on 2008-06-27 21:47:06 as **
  • Selective Induction of High Avidity CTL by Altering the Balance of Signals from APC
    J Immunol, Vol. 170, No. 5. (1 March 2003), pp. 2523-2530.
    by Sangkon Oh, James W Hodge, Jeffrey D Ahlers, Donald S Burke, Jeffrey Schlom, Jay A Berzofsky
    posted to avidity by eisei on 2008-06-27 21:46:20 as **
  • High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
    J Immunol, Vol. 162, No. 2. (15 January 1999), pp. 989-994.
    by Herbert J Zeh, Donna Perry-Lalley, Mark E Dudley, Steven A Rosenberg, James C Yang
    posted to avidity by eisei on 2008-06-27 21:32:42 as **
  • Isolation of High Avidity Melanoma-Reactive CTL from Heterogeneous Populations Using Peptide-MHC Tetramers
    J Immunol, Vol. 162, No. 4. (15 February 1999), pp. 2227-2234.
    by Cassian Yee, Peter A Savage, Peter P Lee, Mark M Davis, Philip D Greenberg
    posted to avidity by eisei on 2008-06-27 21:32:10 as ** along with 1 person eghorani
  • In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity
    J. Virol., Vol. 74, No. 13. (1 July 2000), pp. 5769-5775.
    by C Sedlik, G Dadaglio, MF Saron, E Deriaud, M Rojas, SI Casal, C Leclerc
    posted to avidity by eisei on 2008-06-27 21:30:30 as **
  • IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells
    Proceedings of the National Academy of Sciences, Vol. 101, No. 42. (19 October 2004), pp. 15154-15159.
    by Sangkon Oh, Liyanage P Perera, Donald S Burke, Thomas A Waldmann, Jay A Berzofsky
    posted to avidity by eisei on 2008-06-27 21:29:41 as **
  • Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy
    Proceedings of the National Academy of Sciences, Vol. 93, No. 9. (30 April 1996), pp. 4102-4107.
    by Martha A Alexander-Miller, Graham R Leggatt, Jay A Berzofsky
    posted to avidity by eisei on 2008-06-27 21:25:40 as ** along with 1 person kpavelko
  • Cutting Edge: Dendritic Cells Prime a High Avidity CTL Response Independent of the Level of Presented Antigen
    J Immunol, Vol. 180, No. 9. (1 May 2008), pp. 5784-5788.
    by Charles J Kroger, Samuel Amoah, Martha A Alexander-Miller
    posted to avidity by eisei on 2008-06-27 21:13:25 as **
  • Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.
    BMC gastroenterology, Vol. 4 (23 September 2004)
    by AA Bahnassy, AR Zekri, S El-Houssini, AM El-Shehaby, MR Mahmoud, S Abdallah, M El-Serafi
    posted to cyclin-a by eisei on 2008-06-27 18:06:49 as **
  • Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis.
    International journal of cancer. Journal international du cancer, Vol. 84, No. 3. (21 June 1999), pp. 225-233.
    by K Handa, M Yamakawa, H Takeda, S Kimura, T Takahashi
    posted to cyclin-a by eisei on 2008-06-27 18:06:05 as **
  • A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer
    Oncogene, Vol. aop, No. current.
    by Barbara Wegiel, Anders Bjartell, Jenny Ekberg, Virgil Gadaleanu, Cecilia Brunhoff, Jenny L Persson, Jenny L Persson
    posted to cyclins cyclin-a1 by eisei on 2008-06-27 18:03:09 as **
  • Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin.
    The Journal of biological chemistry, Vol. 277, No. 44. (1 November 2002), pp. 41960-41969.
    by TB Nguyen, K Manova, P Capodieci, C Lindon, S Bottega, XY Wang, J Refik-Rogers, J Pines, DJ Wolgemuth, A Koff
    posted to cyclins by eisei on 2008-06-27 18:01:54 as **
  • E- and A-type cyclins as markers for cancer diagnosis and prognosis.
    Expert review of molecular diagnostics, Vol. 3, No. 5. (September 2003), pp. 617-633.
    by A Yasmeen, WE Berdel, H Serve, C Müller-Tidow
    posted to cyclins cyclin-a by eisei on 2008-06-27 17:59:16 as **
  • Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment.
    British journal of cancer, Vol. 86, No. 3. (1 February 2002), pp. 402-408.
    by R Michalides, H van Tinteren, A Balkenende, JB Vermorken, J Benraadt, J Huldij, P van Diest
    posted to cyclin-a by eisei on 2008-06-27 17:40:53 as **
  • Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival.
    The Prostate, Vol. 38, No. 3. (15 February 1999), pp. 175-182.
    by S Aaltomaa, M Eskelinen, P Lipponen
    posted to cyclin-d1 cyclin-a by eisei on 2008-06-27 17:38:55 as **
  • Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas.
    The American journal of pathology, Vol. 153, No. 3. (September 1998), pp. 963-972.
    by Y Dobashi, M Shoji, SX Jiang, M Kobayashi, Y Kawakubo, T Kameya
    posted to cyclin-a by eisei on 2008-06-27 17:37:11 as **
  • Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.
    Journal of clinical pathology, Vol. 56, No. 5. (May 2003), pp. 368-373.
    by IR Bukholm, G Bukholm, R Holm, JM Nesland
    posted to cyclin-a by eisei on 2008-06-27 17:34:00 as **
  • A link between cyclin A expression and adhesion-dependent cell cycle progression.
    Science (New York, N.Y.), Vol. 262, No. 5139. (3 December 1993), pp. 1572-1575.
    by TM Guadagno, M Ohtsubo, JM Roberts, RK Assoian
    posted to transfection cyclin-a by eisei on 2008-06-27 17:25:40 as ** along with 1 person catcremona
  • Cyclin A expression in human hematological malignancies: a new marker of cell proliferation.
    Cancer research, Vol. 53, No. 2. (15 January 1993), pp. 235-238.
    by P Paterlini, AM Suberville, F Zindy, J Melle, M Sonnier, JP Marie, F Dreyfus, C Bréchot
    posted to cyclin-a by eisei on 2008-06-27 17:01:54 as **
  • Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1.
    Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 12. (5 June 2001), pp. 6853-6858.
    by C Liao, XY Wang, HQ Wei, SQ Li, T Merghoub, PP Pandolfi, DJ Wolgemuth
    posted to transgenic cyclin-a1 by eisei on 2008-06-27 16:59:06 as **
  • Overexpression of Cyclin A but not Skp 2 Correlates with the Tumor Relapse of Human Hepatocellular Carcinoma
    Cancer Res, Vol. 58, No. 5. (1 March 1998), pp. 985-990.
    by Yee Chao, Yung-Luen Shih, Jen-Hwey Chiu, Gar-Yang Chau, Wing-Yu Lui, Wen K Yang, Shou-Dong Lee, Tze-Sing Huang
    posted to cyclins cyclin-a by eisei on 2008-06-27 16:44:20 as **
  • Cyclin A in cell cycle control and cancer
    Cellular and Molecular Life Sciences (CMLS), Vol. 59, No. 8. (2002), pp. 1317-1326.
    by CH Yam, TK Fung, RYC Poon
    posted to cyclin-a by eisei on 2008-06-27 16:43:03 as **
  • Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells.
    Oncogene, Vol. 24, No. 16. (14 April 2005), pp. 2739-2744.
    by P Ji, S Agrawal, S Diederichs, N Bäumer, A Becker, T Cauvet, S Kowski, C Beger, K Welte, WE Berdel, H Serve, C Müller-Tidow
    posted to cyclins cyclin-a1 cyclin-a by eisei on 2008-06-27 16:37:59 as **
  • Cyclin A1 expression in leukemia and normal hematopoietic cells.
    Blood, Vol. 93, No. 6. (15 March 1999), pp. 2067-2074.
    by R Yang, T Nakamaki, M Lübbert, J Said, A Sakashita, BS Freyaldenhoven, S Spira, V Huynh, C Müller, HP Koeffler
    posted to cyclin-a1 cyclin-a by eisei on 2008-06-27 16:35:58 as **
  • Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation.
    Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, Vol. 12, No. 6. (June 1998), pp. 893-898.
    by A Krämer, A Hochhaus, S Saussele, A Reichert, A Willer, R Hehlmann
    posted to leukemia cyclin-a1 cyclin-a by eisei on 2008-06-27 16:33:04 as **
  • Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients.
    Anticancer research, Vol. 26, No. 6B. (c 2006), pp. 4415-4421.
    by E Baldini, A Camerini, A Sgambato, T Prochilo, A Capodanno, F Pasqualetti, C Orlandini, L Resta, G Bevilacqua, P Collecchi
    posted to cyclin-a breast by eisei on 2008-06-27 16:28:09 as **
  • Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas.
    Cytometry, Vol. 42, No. 4. (15 August 2000), pp. 254-260.
    by P Collecchi, T Santoni, E Gnesi, A Giuseppe Naccarato, A Passoni, M Rocchetta, R Danesi, G Bevilacqua
    posted to cyclins cyclin-a by eisei on 2008-06-27 16:23:43 as **
    • Note: You may cite this page as: http://www.citeulike.org/user/eisei

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX RSS